Feng Guo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Signaling Pathway

Endoplasmic Reticulum Stress

Top Venues

Cancer research

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Li, Feng Guo, Ruijiang Zeng, Huaiyuan Liang, Yinghuai Wang, Wei Xiong, Heshui Wu, Chunguang Yang, Xin Jin
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer research 84 (16) (2024)
Wei Li, Feng Guo, Ruijiang Zeng, Huaiyuan Liang, Yinghuai Wang, Wei Xiong, Heshui Wu, Chunguang Yang, Xin Jin
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer research 84 (16) (2024)
Wei Li, Feng Guo, Ruijiang Zeng, Huaiyuan Liang, Yinghuai Wang, Wei Xiong, Heshui Wu, Chunguang Yang, Xin Jin
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer research (2024)
Yan Sun, Liang Zhu, Pian Liu, Huan Zhang, Feng Guo, Xin Jin
ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma. Cancer research (2023)
Yan Sun, Xin Jin, Junpeng Meng, Feng Guo, Taoyu Chen, Xiaoyan Zhao, Heshui Wu, Dianyun Ren
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. The EMBO journal (2023)
Feng Guo, Xiang Cheng, Boping Jing, Heshui Wu, Xin Jin
FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression. Oncogene 41 (6) (2022)